Deal or Case news
28.05.2020 4 min read
NautaDutilh assists the Netherlands Center for the Clinical advancement of Stem Cell and Gene Therapies (NECSTGEN) with regard to the construction of its new facility at the Leiden Bio Science Park.

There are few facilities such as NECSTGEN around the world: affordable, non-profit facilities that facilitate the product development of regenerative medical treatments – treatments that restore or replace diseased cells, tissues and organs. Regenerative medicine is considered a great promise in the pharmaceutical industry. The NECSTGEN is needed to test breakthroughs, develop them further and make them available to patients more quickly. The NECSTGEN, scheduled to open at the end of this year or early 2021, will help to further strengthen the Netherlands life science and biotech ecosystem.

The NautaDutilh team advising NECSTGEN consists of David van Dijk, Ramon Pop, David van Ee and Ruud Smits.

Related articles

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.